Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06435182 |
| Consolidated Lead Sponsor | Ocumension Therapeutics (Shanghai) Co |
| Therapeutic Condition Cohort | Ophthalmology and Sensory |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 213 participants (ACTUAL) |
| Registered Start Date | 2023-04-10 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The Third Xiangya Hospital of Central South University | Changsha, China | Open Hospital Dossier -> |
| The Second Affiliated Hospital Zhejiang University School of Medicine | Hangzhou, China | Open Hospital Dossier -> |
| Renmin Hospital of Wuhan University | Wuhan, China | Open Hospital Dossier -> |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Ophthalmology and Sensory Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.